Full-Time

Business Development Representative

Confirmed live in the last 24 hours

HeartFlow

HeartFlow

501-1,000 employees

Non-invasive cardiac testing for heart disease

Biotechnology
Healthcare

Compensation Overview

$135kAnnually

Senior

Long Island, New York, USA

Expect approximately 20-25% travel from a home office.

Category
Business Development
Business & Strategy
Required Skills
Sales
Salesforce
Requirements
  • Proven sales skills and track-record of sales achievement
  • Account development - Experience building and supporting strong clinical programs is preferred.
  • Clinical / technical proficiency - Quick learner able to grasp new clinical/technical information and then disseminate to customers.
  • Develop relationships with key account stakeholders, to include admin, admin support, key cardiologists, key referring physician practices, hospital marketing and key strategic personnel to drive awareness of a cCTA/FFRct pathway, broaden HeartFlow referrals, and deepen HeartFlow adoption.
  • Work in a cross functional capacity to coordinate field and HQ resources needed to support focused customers and execute program development plans, support sales, marketing, education and training.
  • Customer-focused mentality.
  • Ability to explain medical technologies to referring physicians and health care professionals.
  • Knowledge of cardiac patient pathways and diagnostic technology is preferred.
  • Self-motivated and ability to initiate, organize, and complete projects.
  • Excellent problem-solving ability, especially under pressure.
  • Extremely strong work ethic.
  • Works well in a cross-functional team environment.
  • Ability to work effectively with customers from a wide range of technical and clinical backgrounds.
  • Excellent verbal and written communication skills. Professional etiquette.
  • Experience with Salesforce.com or similar CRM.
  • 4-year degree with 5+years of related sales or clinical experience or 2-year degree with 7+ years related sales or clinical experience.
  • Degree in Science, Medical, Business, Marketing or Technical field is preferred.
  • Prior experience in medical device, cardiology pharmaceuticals, cardiology radio-pharmaceuticals, hospital, or medical software is highly desired.
  • Experience with introducing new cardiovascular technologies into hospitals is highly desired.
Responsibilities
  • Will work with key strategic HeartFlow accounts to drive growth and adoption of a cCTA and FFRct clinical pathway. In these accounts, the BDR will develop and execute business development plans working closely with the account’s key stakeholders
  • Facilitate cross-functional collaboration throughout the organization. Tools for program development could include key deployment of HeartFlow internal leadership and physician mentors, organizing and staffing of dinner programs, VIP Visits, organizing HeartFlow CT Pathway road-shows, referring physician office meetings, etc. This role will work closely with the other HeartFlow team members to include respective DSM, Marketing, Market Access, CT Apps, Product Development and Clinical
  • Increase HeartFlow usage within the designated key strategic HeartFlow account by: 1) Maintaining and building relationships with referring physicians and other key clinical stakeholders 2) Educating customers on HeartFlow’s value proposition by giving presentations / having discussions with referring MDs 3) Promoting / championing HeartFlow and building advocacy
  • Production/Success/Achievement of the Business Development Representative will be evaluated and based on performance in active/targeted accounts(metrics): 1) Meet / exceed quota for the strategic HeartFlow account (within existing customer locations) 2) cCTA growth (conversion of non-invasive tests) and FFRct penetration / case growth over baseline (% and $) in assigned accounts.

HeartFlow provides a non-invasive cardiac test that offers detailed images of a patient's coronary arteries, helping doctors to diagnose and treat heart disease more effectively. The technology works by creating a comprehensive analysis of the heart's condition without the need for invasive procedures, which reduces risks for patients and lowers costs for healthcare providers. Unlike many competitors, HeartFlow's product has received FDA clearance and is available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. The company's goal is to enhance cardiovascular care by making diagnosis and treatment safer and more efficient for both patients and healthcare professionals.

Company Stage

Series F

Total Funding

$858.5M

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

4%

1 year growth

16%

2 year growth

18%
Simplify Jobs

Simplify's Take

What believers are saying

  • HeartFlow closed a $215 million Series F funding round to expand its product portfolio.
  • The global market for non-invasive cardiac imaging is projected to grow significantly.
  • HeartFlow's AI-enabled tools align with the trend towards value-based healthcare.

What critics are saying

  • Increased competition from emerging AI-driven cardiovascular diagnostic companies could erode market share.
  • Regulatory scrutiny on AI-based medical devices could delay product approvals.

What makes HeartFlow unique

  • HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.
  • Their AI-driven FFRCT Analysis provides a non-invasive alternative to traditional cardiac tests.
  • HeartFlow's technology is FDA-cleared and commercially available in major global markets.

Help us improve and share your feedback! Did you find this helpful?